Monterey Bio Acquisition (MTRYW) Stock Analysis

What Monterey Bio Acquisition does

Monterey Bio Acquisition Corporation's primary objective is to finalize a business combination with one or more entities, employing strategies such as a merger, capital stock exchange, asset acquisition, stock purchase, or corporate reorganization. Its acquisition efforts are strategically directed towards the biotechnology sector. The company was established in 2020 and is headquartered in New York, New York. Notably, it previously operated as Chardan FinTech Acquisition Corp. before officially adopting the name Monterey Bio Acquisition Corporation in April 2021.

Key metrics

ETFs linked to MTRYW

Broad-market and Financial Services sector ETFs an investor holding Monterey Bio Acquisition is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MTRYW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Monterey Bio Acquisition?

Monterey Bio Acquisition trades under the ticker MTRYW on NASDAQ.

Which exchange is MTRYW listed on?

MTRYW is listed on NASDAQ.

What sector does Monterey Bio Acquisition operate in?

Monterey Bio Acquisition is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze MTRYW in a portfolio?

PortView shows MTRYW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.